Sector: Health Care
Director information for LABCORP HOLDINGS INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ADAM H. SCHECHTER | Chairman, President, and Chief Executive Officer | 61 | ["Chairman, President, and Chief Executive Officer, Labcorp Holdings Inc.","Global and U.S.-focused leadership roles at Merck","Deep knowledge of the pharmaceutical and healthcare industries","Experience collaborating with key stakeholders","CERT Certificate in Cybersecurity Oversight"] | ["Academic Affairs Committee","Mission and Identity Committee"] | 2026 |
| Dr. Kong | Committee Chair | [] | ["Nominating and Corporate Governance Committee"] | 2026 | |
| Dr. Rothman | [] | ["Quality and Compliance Committee"] | 2026 | ||
| Garheng Kong | Lead Independent Director, Vice Chairman of the Board | ["Knowledge and experience in both the healthcare and finance fields","Executive leadership experience","Life science-related venture capital experience","Corporate governance expertise through service on public company boards"] | ["Nominating and Corporate Governance Committee","Compensation and Human Capital Committee"] | 2026 | |
| GARHENG KONG, M.D., PH.D | Managing Partner | 50 | ["Managing Partner, HealthQuest Capital"] | ["CHAIR"] | 2026 |
| GARHENG KONG, M.D., PH.D. | Vice Chairman and Lead Independent Director | [] | ["Quality and Compliance Committee"] | 2026 | |
| JEFFREY A. DAVIS | Former Chief Financial Officer; Chair; Director | 62 | ["Former Chief Financial Officer, Dollar Tree, Inc.","Certified public accountant (inactive)","Bachelor of Science in Accounting from the Pennsylvania State University","Master of Business Administration from the University of Pittsburgh","Experience as Chief Financial Officer across multiple industries","Audit committee financial expert","Executive leadership experience","Financial management expertise","Public company leadership experience","audit committee financial expert","accounting or related financial management expertise"] | ["CHAIR","Audit Committee","Quality and Compliance Committee"] | 2026 |
| John H. Sampson | Director | ["Practicing neurosurgeon","Richard D. Krugman Endowed Chair","Vice Chancellor for Health Affairs","Dean of the University of Colorado Anschutz School of Medicine","President of CU Medicine","Senior Vice President in the Duke University Health System","Led the Duke Health Integrated Practice","Bachelor of Science degree from the University of Manitoba","Doctor of Medicine from the University of Manitoba","Master of Health Science in clinical research from Duke University","Master of Business Administration from Duke University’s Fuqua School of Business","Extensive experience in the healthcare industry","Scientific expertise in oncology, neuroscience, and immunology","Expertise in supervising cybersecurity matters"] | ["Quality and Compliance Committee"] | 2026 | |
| JOHN H. SAMPSON, M.D., PH.D | Vice Chancellor and Dean | 59 | ["Vice Chancellor and Dean, University of Colorado Anschutz School of Medicine"] | [] | 2026 |
| JOHN H. SAMPSON, M.D., PH.D. | [] | [] | 2026 | ||
| KATHRYN E. WENGEL | Executive Vice President, Chief Technical Operations & Risk Officer | 60 | ["Executive Vice President, Chief Technical Operations & Risk Officer","Healthcare expertise","Operations expertise","Global business experience","Leadership positions at Johnson & Johnson","Extensive global experience in managing complex supply chains","Executive leadership experience","Knowledge and experience in the healthcare field","Long-term experience with corporate sustainability matters","Advocate and sponsor of diversity initiatives"] | ["Compensation and Human Capital Committee","Quality and Compliance Committee"] | 2026 |
| KERRII B. ANDERSON | Former Chief Executive Officer; Director | 68 | ["Former Chief Executive Officer, Wendy’s International, Inc.","Strong record of leadership in operations and strategy","Audit committee financial expert with chief executive officer and chief financial officer experience","Extensive public company board, governance, and audit committee experience","Extensive financial, mergers and acquisitions, international, talent management, corporate governance, and executive compensation experience","CERT Certificate in Cyber-Risk Oversight from the Carnegie Mellon University Software Engineering Institute","audit committee financial expert","accounting or related financial management expertise"] | ["Audit Committee","Nominating and Corporate Governance Committee"] | 2026 |
| KIRSTEN M. KLIPHOUSE | Former President; Director | 59 | ["Former President, Google Cloud Americas","President of Google Cloud Americas","Senior Vice President at Red Hat, Inc.","Chief Executive Officer of Yardarm Technologies","Founder and Chief Executive Officer of Scaling Ventures","More than 25 years at Microsoft, Inc."] | ["Audit Committee"] | 2026 |
| Paul B. Rothman | Director | ["Rheumatologist and molecular immunologist","Former Dean of the Medical Faculty for Johns Hopkins University School of Medicine","CEO of Johns Hopkins Medicine","Leadership positions at Columbia University and the University of Iowa","Bachelor of Science in Biology from the Massachusetts Institute of Technology","Doctor of Medicine from Yale University","Extensive expertise in patient care, science, and medicine relevant to the clinical laboratory business","Operational, management, and executive leadership experience","Deep understanding of the complexity of the U.S. healthcare delivery system and policy development"] | ["Quality and Compliance Committee","Compensation and Human Capital Committee"] | 2026 | |
| PAUL B. ROTHMAN, M.D. | Former Dean of the Medical Faculty; Chair | 68 | ["Former Dean of the Medical Faculty for Johns Hopkins University School of Medicine"] | ["CHAIR"] | 2026 |
| PETER M. NEUPERT | Former Operating Partner; Director | 70 | ["Former Operating Partner, Health Evolution Partners","Expertise in health information technology","Shareholder value creation and leveraging business strategies with technology","Audit committee financial expert with chief executive officer experience","Corporate governance and business strategy expertise","Expertise and experience in cybersecurity matters"] | ["Nominating and Corporate Governance Committee"] | 2026 |
| RICHELLE P. PARHAM | Former President of Global E-Commerce and Business Development; Chair; Director | 58 | ["Former President of Global E-Commerce and Business Development, Universal Music Group","Extensive senior-level executive experience, including in corporate finance, and mergers and acquisitions","More than 20 years of global strategy and marketing experience","Expertise in understanding consumers and the consumer decision journey"] | ["CHAIR","Compensation and Human Capital Committee","Nominating and Corporate Governance Committee"] | 2026 |
| VICTOR BULTO | President of Novartis US | 47 | ["Master’s in Health Economics and Pharmacoeconomics","Postgraduate Degree in Pharmaceutical Marketing","MBA from ESADE","Advanced Management Program at Harvard Business School","Master of Science in Chemical Engineering","Bachelor of Science in Chemistry","Extensive experience in the healthcare industry","Proven track record of leading large, complex organizations across the U.S. and Europe"] | ["Audit Committee"] | 2026 |
